Reviva Pharmaceuticals Warrants
RVPHW
RVPHW was delisted on the 12th of December, 2025.
15 hedge funds and large institutions have $2.38M invested in Reviva Pharmaceuticals Warrants in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and closing their positions.
291% more capital invested
Capital invested by funds: $607K → $2.38M (+$1.77M)
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
25% more funds holding
Funds holding: 12 → 15 (+3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
BlueCrest Capital Management
St Helier,
Jersey
|
+$50.4K |
| 2 |
Walleye Trading
New York
|
+$49.7K |
| 3 |
BFM
Boothbay Fund Management
New York
|
+$38.6K |
| 4 |
GCIA
Gabelli & Co Investment Advisers
Rye,
New York
|
+$38.5K |
| 5 |
GF
Gabelli Funds
Rye,
New York
|
+$23.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CI
Cowen Inc
New York
|
-$25.9K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BFM
1
Boothbay Fund Management
New York
| $1.96M | +$38.6K | +195,065 | New |
|
|
BCM
2
BlueCrest Capital Management
St Helier,
Jersey
| $97K | +$50.4K | +254,500 | +73% |
|
|
GCL
3
Glazer Capital LLC
New York
| $47K | +$8.13K | +41,026 | +16% |
|
|
OAM
4
Oxford Asset Management
Oxford,
United Kingdom
| $43K | – | – | – |
|
|
5
Walleye Trading
New York
| $42K | +$49.7K | +251,067 | +2,282% |
|
|
AA
6
AQR Arbitrage
Greenwich,
Connecticut
| $40K | – | – | – |
|
|
6CM
7
683 Capital Management
New York
| $32K | – | – | – |
|
|
GCIA
8
Gabelli & Co Investment Advisers
Rye,
New York
| $31K | +$38.5K | +194,500 | New |
|
|
PAM
9
Panagora Asset Management
Boston,
Massachusetts
| $19K | – | – | – |
|
|
GF
10
Gabelli Funds
Rye,
New York
| $19K | +$23.4K | +118,200 | New |
|
|
BCM
11
Bluefin Capital Management
New York
| $14K | – | – | – |
|
|
BI
12
Bulldog Investors
Saddle Brook,
New Jersey
| $9K | – | – | – |
|
|
CI
13
Cowen Inc
New York
| $6K | -$25.9K | -130,708 | -76% |
|
|
PC
14
Periscope Capital
Toronto,
Ontario, Canada
| $6K | – | – | – |
|
|
PAMP
15
Polar Asset Management Partners
Toronto,
Ontario, Canada
| $6K | – | – | – |
|
RVPHW Hedge Fund Activity: Q1 2019 in Review
15 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Reviva Pharmaceuticals Warrants (RVPHW) for Q1 2019, worth a combined $2.38M — up 291% from $607K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new RVPHW positions and 0 closed out — a net gain of 3 holders — while 3 added to existing stakes and 1 trimmed.
The largest buyer was BlueCrest Capital Management, adding an estimated $50.4K. The largest seller was Cowen Inc, cutting an estimated $25.9K.
- 15 institutional investors held Reviva Pharmaceuticals Warrants (RVPHW) as of Q1 2019, up from 12 in Q4 2018.
- Funds reported $2.38M of Reviva Pharmaceuticals Warrants stock for Q1 2019, up 291% quarter-over-quarter.
- 3 funds opened new Reviva Pharmaceuticals Warrants positions in Q1 2019 and 0 closed out, a net change of +3 holders.
- The largest Reviva Pharmaceuticals Warrants buyer in Q1 2019 was BlueCrest Capital Management, an estimated $50.4K added.
- The largest Reviva Pharmaceuticals Warrants seller in Q1 2019 was Cowen Inc, an estimated $25.9K sold.
Based on aggregated 13F filings for Q1 2019.